Incubate Coalition

WASHINGTON (October 22) -- Today, the U.S. Department of the Treasury proposed regulations implementing the Comprehensive Outbound Investment National Security (COINS) Act. The proposal would restrict certain U.S. investments in Chinese biotechnology companies, including those involved in drug development, genetic sequencing, and biomanufacturing. The rules would affect several forms of investment, including equity investments, certain financing arrangements, and joint ventures. Incubate's...

WASHINGTON (September 30) -- Today, the Centers for Medicare & Medicaid Services moved to finalize the Global Benchmark for Efficient Drug Pricing (GLOBE) model. Incubate's executive director, John Stanford, issued the following statement: "Incubate opposes the GLOBE demonstration model because it moves Medicare further down the path toward government-imposed drug pricing tied to foreign government price controls. "Developing a new medicine takes years of research, billions of dollars in...